Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Income (Loss) from Equity Method Investments

3.0 / 5 stars · 61/101 Roast Me

BIOMARIN PHARMACEUTICAL INC Income (Loss) from Equity Method Investments

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Income (Loss) from Equity Method Investments of $177.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-29.

Discontinued › Income Statement › Other Income

us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-10-29

  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for the quarter ending 2021-09-30 was $177.00K.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for the quarter ending 2021-06-30 was -$175.00K.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for the quarter ending 2021-03-31 was -$1.35M.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for the quarter ending 2020-12-31 was $1.07M, a 454.92% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for fiscal 2020 was -$6.00K.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for fiscal 2019 was -$587.00K.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for fiscal 2018 was -$553.00K.
  • BIOMARIN PHARMACEUTICAL INC income (loss) from equity method investments for fiscal 2017 was -$1.29M.
Period endIncome (Loss) from Equity Method Investments 3 monthIncome (Loss) from Equity Method Investments 3 month as first filedIncome (Loss) from Equity Method Investments 6 monthIncome (Loss) from Equity Method Investments 9 monthIncome (Loss) from Equity Method Investments 12 month
2021-09-30$177.00K
10-Q · filed 2021-10-29
$2.00K
derived: sum of 2 quarters · filed 2021-10-29
-$1.35M
10-Q · filed 2021-10-29
-$278.00K
derived: sum of 4 quarters · filed 2021-10-29
2021-06-30-$175.00K
10-Q · filed 2021-07-30
-$1.53M
10-Q · filed 2021-07-30
-$455.00K
derived: sum of 3 quarters · filed 2021-07-30
-$1.38M
derived: sum of 4 quarters · filed 2021-10-29
2021-03-31-$1.35M
10-Q · filed 2021-04-30
-$280.00K
derived: sum of 2 quarters · filed 2021-04-30
-$1.20M
derived: sum of 3 quarters · filed 2021-10-29
-$1.28M
derived: sum of 4 quarters · filed 2021-10-29
2020-12-31$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$150.00K
derived: sum of 2 quarters · filed 2021-10-29
$71.00K
derived: sum of 3 quarters · filed 2021-10-29
-$6.00K
10-K · filed 2021-02-26
2020-09-30-$921.00K
10-Q · filed 2021-10-29
-$1.00M
derived: sum of 2 quarters · filed 2021-10-29
-$1.08M
10-Q · filed 2021-10-29
-$884.00K
derived: sum of 4 quarters · filed 2021-10-29
2020-06-30-$79.00K
10-Q · filed 2021-07-30
-$156.00K
10-Q · filed 2021-07-30
$37.00K
derived: sum of 3 quarters · filed 2021-07-30
-$514.00K
derived: sum of 4 quarters · filed 2021-07-30
2020-03-31-$77.00K
10-Q · filed 2021-04-30
$116.00K
derived: sum of 2 quarters · filed 2021-04-30
-$435.00K
derived: sum of 3 quarters · filed 2021-04-30
-$479.00K
derived: sum of 4 quarters · filed 2021-04-30
2019-12-31$193.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
-$358.00K
derived: sum of 2 quarters · filed 2021-02-26
-$402.00K
derived: sum of 3 quarters · filed 2021-02-26
-$587.00K
10-K · filed 2021-02-26
2019-09-30-$551.00K
10-Q · filed 2020-11-06
-$595.00K
derived: sum of 2 quarters · filed 2020-11-06
-$780.00K
10-Q · filed 2020-11-06
-$826.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$44.00K
10-Q · filed 2020-08-05
-$229.00K
10-Q · filed 2020-08-05
-$275.00K
derived: sum of 3 quarters · filed 2021-02-26
-$743.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$185.00K
10-Q · filed 2020-05-01
-$231.00K
derived: sum of 2 quarters · filed 2021-02-26
-$699.00K
derived: sum of 3 quarters · filed 2021-02-26
-$806.00K
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$46.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
-$514.00K
derived: sum of 2 quarters · filed 2021-02-26
-$621.00K
derived: sum of 3 quarters · filed 2021-02-26
-$553.00K
10-K · filed 2021-02-26
2018-09-30-$468.00K
10-Q/A · filed 2019-11-04
-$575.00K
derived: sum of 2 quarters · filed 2019-11-04
-$507.00K
10-Q/A · filed 2019-11-04
-$802.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$107.00K
10-Q · filed 2019-08-02
-$39.00K
10-Q · filed 2019-08-02
-$334.00K
derived: sum of 3 quarters · filed 2020-02-27
-$587.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$68.00K
10-Q · filed 2019-04-29
-$227.00K
derived: sum of 2 quarters · filed 2020-02-27
-$480.00K
derived: sum of 3 quarters · filed 2020-02-27
-$700.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$295.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$548.00K
derived: sum of 2 quarters · filed 2020-02-27
-$768.00K
derived: sum of 3 quarters · filed 2020-02-27
-$1.29M
10-K · filed 2020-02-27
2017-09-30-$253.00K
10-Q · filed 2018-10-26
-$473.00K
derived: sum of 2 quarters · filed 2018-10-26
-$996.00K
10-Q · filed 2018-10-26
-$1.16M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$220.00K
10-Q · filed 2018-08-03
-$743.00K
10-Q · filed 2018-08-03
-$907.00K
derived: sum of 3 quarters · filed 2019-02-28
-$1.01M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$523.00K
10-Q · filed 2018-04-27
-$687.00K
derived: sum of 2 quarters · filed 2019-02-28
-$791.00K
derived: sum of 3 quarters · filed 2019-02-28
-$926.00K
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$164.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$268.00K
derived: sum of 2 quarters · filed 2019-02-28
-$403.00K
derived: sum of 3 quarters · filed 2019-02-28
-$538.00K
10-K · filed 2019-02-28
2016-09-30-$104.00K
10-Q · filed 2017-10-31
-$239.00K
derived: sum of 2 quarters · filed 2017-10-31
-$374.00K
10-Q · filed 2017-10-31
-$652.00K
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$135.00K
10-Q · filed 2017-08-02
-$270.00K
10-Q · filed 2017-08-02
-$548.00K
derived: sum of 3 quarters · filed 2018-02-26
-$734.00K
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$135.00K
10-Q · filed 2017-05-04
-$413.00K
derived: sum of 2 quarters · filed 2018-02-26
-$599.00K
derived: sum of 3 quarters · filed 2018-02-26
-$802.00K
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$278.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$464.00K
derived: sum of 2 quarters · filed 2018-02-26
-$667.00K
derived: sum of 3 quarters · filed 2018-02-26
-$817.00K
10-K · filed 2018-02-26
2015-09-30-$186.00K
10-Q · filed 2016-11-03
-$389.00K
derived: sum of 2 quarters · filed 2016-11-03
-$539.00K
10-Q · filed 2016-11-03
-$314.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$203.00K
10-Q · filed 2016-08-08
-$204.00K
10-Q · filed 2015-08-05
-$353.00K
10-Q · filed 2016-08-08
-$128.00K
derived: sum of 3 quarters · filed 2017-02-27
-$353.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$150.00K
10-Q · filed 2016-05-02
$75.00K
derived: sum of 2 quarters · filed 2017-02-27
-$150.00K
derived: sum of 3 quarters · filed 2017-02-27
-$689.00K
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$225.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$0.00
derived: sum of 2 quarters · filed 2017-02-27
-$539.00K
derived: sum of 3 quarters · filed 2017-02-27
-$877.00K
10-K · filed 2017-02-27
2014-09-30-$225.00K
10-Q · filed 2015-11-02
-$764.00K
derived: sum of 2 quarters · filed 2015-11-02
-$1.10M
10-Q · filed 2015-11-02
-$1.54M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$539.00K
10-Q · filed 2015-08-05
-$877.00K
10-Q · filed 2015-08-05
-$1.31M
derived: sum of 3 quarters · filed 2016-02-29
-$1.46M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$338.00K
10-Q · filed 2015-05-05
-$776.00K
derived: sum of 2 quarters · filed 2016-02-29
-$923.00K
derived: sum of 3 quarters · filed 2016-02-29
-$1.09M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$438.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$585.00K
derived: sum of 2 quarters · filed 2016-02-29
-$748.00K
derived: sum of 3 quarters · filed 2016-02-29
-$1.15M
10-K · filed 2016-02-29
2013-09-30-$147.00K
10-Q · filed 2014-10-28
-$310.00K
derived: sum of 2 quarters · filed 2014-10-28
-$711.00K
10-Q · filed 2014-10-28
-$964.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$163.00K
10-Q · filed 2014-07-31
-$564.00K
10-Q · filed 2014-07-31
-$817.00K
derived: sum of 3 quarters · filed 2015-03-02
-$1.15M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$401.00K
10-Q · filed 2014-05-02
-$654.00K
derived: sum of 2 quarters · filed 2015-03-02
-$990.00K
derived: sum of 3 quarters · filed 2015-03-02
-$888.00K
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$253.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$589.00K
derived: sum of 2 quarters · filed 2015-03-02
-$487.00K
derived: sum of 3 quarters · filed 2015-03-02
-$1.22M
10-K · filed 2015-03-02
2012-09-30-$336.00K
10-Q · filed 2013-10-28
-$234.00K
derived: sum of 2 quarters · filed 2013-10-28
-$968.00K
10-Q · filed 2013-10-28
-$1.58M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$102.00K
10-Q · filed 2013-07-29
-$632.00K
10-Q · filed 2013-07-29
-$1.24M
derived: sum of 3 quarters · filed 2014-02-26
-$1.85M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31-$734.00K
10-Q · filed 2013-04-29
-$1.34M
derived: sum of 2 quarters · filed 2014-02-26
-$1.95M
derived: sum of 3 quarters · filed 2014-02-26
-$2.62M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31-$609.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
-$1.22M
derived: sum of 2 quarters · filed 2014-02-26
-$1.88M
derived: sum of 3 quarters · filed 2014-02-26
-$2.43M
10-K · filed 2014-02-26
2011-09-30-$608.00K
10-Q · filed 2012-10-29
-$1.27M
derived: sum of 2 quarters · filed 2012-10-29
-$1.82M
10-Q · filed 2012-10-29
-$2.61M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$667.00K
10-Q · filed 2012-08-02
-$1.21M
10-Q · filed 2012-08-02
-$2.01M
derived: sum of 3 quarters · filed 2013-02-26
-$2.65M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$542.00K
10-Q · filed 2012-04-30
-$1.34M
derived: sum of 2 quarters · filed 2013-02-26
-$1.98M
derived: sum of 3 quarters · filed 2013-02-26
-$2.84M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31-$797.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
-$1.44M
derived: sum of 2 quarters · filed 2013-02-26
-$2.30M
derived: sum of 3 quarters · filed 2013-02-26
-$2.99M
10-K · filed 2013-02-26
2010-09-30-$639.00K
10-Q · filed 2011-10-31
-$1.50M
derived: sum of 2 quarters · filed 2011-10-31
-$2.19M
10-Q · filed 2010-10-29
-$3.02M
derived: sum of 4 quarters · filed 2012-02-22
2010-06-30-$864.00K
10-Q · filed 2011-08-01
-$1.55M
10-Q · filed 2011-08-01
-$2.38M
derived: sum of 3 quarters · filed 2012-02-22
-$3.06M
derived: sum of 4 quarters · filed 2012-02-22
2010-03-31-$691.00K
10-Q · filed 2011-04-29
-$1.51M
derived: sum of 2 quarters · filed 2012-02-22
-$2.19M
derived: sum of 3 quarters · filed 2012-02-22
-$2.74M
derived: sum of 4 quarters · filed 2012-02-22
2009-12-31-$821.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
-$1.50M
derived: sum of 2 quarters · filed 2012-02-22
-$2.05M
derived: sum of 3 quarters · filed 2012-02-22
-$2.59M
10-K · filed 2012-02-22
2009-09-30-$680.00K
10-Q · filed 2010-10-29
-$1.23M
derived: sum of 2 quarters · filed 2010-10-29
-$1.77M
10-Q · filed 2010-10-29
2009-06-30-$546.00K
10-Q · filed 2010-08-04
-$1.09M
10-Q · filed 2010-08-04
2008-12-31-$2.27M
10-K · filed 2011-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05